Hormonal impact of salvage chemotherapy with carboplatin plus weekly docetaxel in patients with castration- and docetaxel-resistant prostate cancer (DRPC). Methods: Parametric models used are based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback